Pharmafile Logo
Pharmafocus logo
Advanced Search

J&J chalks up ninth product recall in 2010

August 26, 2010
Manufacturing and Production J&J, JJ

 Johnson & Johnson has recalled around 100,000 boxes of its disposable contact lens because of a manufacturing defect, bringing the …

News

Alcon acquisition makes Novartis eyecare leader

August 26, 2010
Sales and Marketing Novartis, ophthalmology

Novartis has finalised its takeover of Alcon that will make it the world’s number one company in ophthalmology. Alcon is …

News
Velcade

Janssen to appeal against Velcade decision

August 26, 2010
Medical Communications, Sales and Marketing NICE, Thalidomide, Velcade, multiple myeloma

Celgene’s Thalidomide has been recommended by NICE for multiple myeloma ahead of Janssen-Cilag’s Velcade. A final appraisal determination says that …

News

NICE updates guidance for arthritis treatments

August 26, 2010
Sales and Marketing NICE, Roche, rheumatoid arthritis

Five new drugs for rheumatoid arthritis have been given the thumbs up by NICE as second line treatment. Roche’s MabThera, …

News

Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 2

August 26, 2010
Research and Development Kinapse, White paper, life sciences, pharma

With fierce competition in the market for late stage life sciences assets, pharmaceutical companies seeking partnering strategies to bolster pipelines …

Feature
White paper
Multaq

Multaq given limited approval from NICE

August 25, 2010
Medical Communications, Sales and Marketing Multaq, NICE, Sanofi-Aventis, atrial, dronedarone

NICE has given a restricted approval to Sanofi-Aventis’s Multaq as a second line treatment for atrial fibrillation patients. The guidance …

News

Avastin patient access scheme too complicated, says NICE

August 25, 2010
Sales and Marketing NICE, avastin, patient access

NICE is set to say no again to Avastin for use in patients with colorectal cancer. Avastin was first launched …

News

Roche signs $1bn peptide deal with Aileron

August 25, 2010
Research and Development, Sales and Marketing Aileron, Roche, peptide, stapled peptide therapeutics

Roche has entered an agreement with a US biopharma company Aileron Therapeutics to develop and commercialise drugs called Stapled Peptide …

News

Sutent disappoints in lung cancer

August 24, 2010
Research and Development, Sales and Marketing NSCLC, Pfizer, Sutent, Tarceva

Pfizer’s Sutent has failed to improve overall survival in lung cancer patients when combined with Roche’s Tarceva. Pfizer’s SUN 1087 …

News
LifeAppts

New joiners at Life

August 24, 2010
Medical Communications Life, Life healthcare communications, appointment, medical communications

Several new faces have joined the regulars at Life Healthcare Communications – seen here in the Hernes Oak (a pub …

Appointment

J&J appoints quality tsar to oversee manufacturing revamp

August 24, 2010
Manufacturing and Production J&J, JJ, recalls

 Johnson & Johnson plans to beef up senior management across its three business units as part of a broader programme …

News

‘Smart’ vial cap reminds patients to take their medicine

August 24, 2010
Manufacturing and Production Med Time, Rexam

 UK packaging giant Rexam has thrown its weight behind a ‘smart’ pill vial that reminds patients when to take their …

News

Avandia letter misleading, FDA tells Glaxo

August 24, 2010
Sales and Marketing Avandia, GSK

GlaxoSmithKline’s travails over controversial diabetes drug Avandia show no sign of abating as members of a key regulatory panel accused …

News
PakistanFloodWEB

Pharma provides aid for Pakistan

August 24, 2010
Sales and Marketing GSK, NGO, Novartis, Pakistan, disaster, pharma, relief

 The pharma industry is providing donations to help those affected by the mass flooding across Pakistan. As many as 20 …

News

Manufacturing news in brief

August 24, 2010
Manufacturing and Production AMRI, Genmab, SAFC Pharma, Stirling Pharmaceuticals

 UK contract manufacturer Aesica has invested £3 million in a high-containment manufacturing facility at its site in Queenborough, Kent, that …

News

Encouraging data for Eisai epilepsy drug

August 24, 2010
Sales and Marketing Eisai, epilepsy, perampanel, phase III, seizures, study 306

A new phase III study for Eisai’s perampanel (E2007) suggests the first-in-class treatment is effective as an adjunctive treatment of …

News

GSK shingles vaccine enters late stage trials

August 23, 2010
Research and Development, Sales and Marketing GSK, Vaccine, shingles

GlaxoSmithKline has started enrollment for phase III trials for its herpes zoster vaccine for the prevention of shingles. The trials …

News

Greece set for further price cuts

August 23, 2010
Sales and Marketing Greece

The Greek government is set to impose price cuts of more than 10% and will further cut reimbursement for a …

News

Hospital consultants’ bonuses to be reviewed

August 23, 2010
Sales and Marketing NHS, consultants

NHS consultants could soon be among those to feel the sting of government cutbacks, according to the secretary of state …

News
Roche

Roche to acquire digital pathology specialists

August 23, 2010
Research and Development, Sales and Marketing Diagnostics, Roche

Roche has added to its portfolio of diagnostics products by acquiring US company BioImagene. The privately held Californian company specialises …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026